ACHL
Achilles Therapeutics plc
Achilles Therapeutics plc (ACHL) is currently in an uptrend, trading above both the 50-day and 200-day moving averages. RSI is at 76.4 (overbought), with 3/3 trend checks passing.
ACHL with MA50 and MA200
Key levels & signals
ACHL valuation multiples (TTM)
ACHL analyst consensus
Achilles Therapeutics plc (ACHL) is still trading in a constructive trend overall. The latest available price is $1.48, and 3 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 12.1% and above the 200-day moving average by 45.1%.
ACHL currently has an RSI reading of 76.4, which points to very strong short-term momentum but also a fairly extended setup. Stocks can stay strong for longer than expected, but this kind of reading often tells beginners not to confuse strength with low-risk entry timing.
For traders reviewing ACHL next, the key question is whether the trend still looks healthy or whether price has started to outrun itself. A strong uptrend can stay strong, but entries often become more difficult when price is already extended, so many traders will watch for pullbacks, support reactions, or fresh bases rather than chasing strength blindly.
About Achilles Therapeutics plc
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
ACHL shares outstanding over time
Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.
Learn the indicators behind this page
More stock opportunities
Common questions about ACHL
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.